Is Becton Dickinson Stock (BDX) Halal? A Complete Analysis

The Short Answer

Becton Dickinson stock (BDX) is generally considered halal by most Islamic scholars and Sharia screening criteria. BD is one of the world's largest medical-technology companies, with a portfolio spanning medical devices, diagnostics, and life-sciences instruments.

Medical-device, diagnostics, and life-sciences-instrument manufacturing is permissible at the activity level under standard Sharia methodology — BD's products serve essential healthcare needs. The primary consideration is the company's leverage following the C. R. Bard acquisition, which should be verified against the 33% debt-to-market-cap threshold.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

• Business activity screen: Is the company's primary business halal?
• Debt ratio: Total debt / market cap must be under 33%
• Interest income: Interest income / total revenue must be under 5%
• Haram revenue: Revenue from haram sources must be under 5%
• Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

Becton Dickinson's Business Activity

BD operates three reporting segments:

• BD Medical: The largest segment, including syringes and needles, medication-management systems such as the Pyxis automated dispensing platform and the Alaris infusion-pump system, prefillable drug-delivery systems for pharmaceutical partners, and diabetes-care products
• BD Life Sciences: Specimen-collection products including the iconic Vacutainer blood-collection system, integrated diagnostic instruments and reagents for infectious-disease and other testing, and flow-cytometry and research instruments
• BD Interventional: Surgical and peripheral-intervention products, urology and critical-care products, and the Bard portfolio acquired in 2017 including vascular, oncology, and surgical-specialty devices

Medical-device and diagnostics manufacturing is unambiguously permissible at the activity level under standard Sharia methodology.

Concerns to Be Aware Of

1. Debt-to-Market-Cap Ratio

BD took on substantial debt to fund the 2017 C. R. Bard acquisition and has been deleveraging through free cash flow generation. The consolidated debt-to-market-cap ratio sits in a manageable range that should be verified against the 33% Sharia threshold at the time of investment.

2. Planned Business Separation

BD announced plans to separate its Biosciences and Diagnostic Solutions business. Investors should verify the current corporate structure at the time of investment, as a separation may change the company's financial profile.

3. Minor Interest Income

BD holds cash and short-term investment balances that generate small interest income. This is well below the 5% Sharia threshold but warrants purification of a small portion of dividends.

Financial Ratios (2025)

Based on Becton Dickinson's most recent financial statements:

• Total Debt / Market Cap: Verify against 33% threshold — elevated by Bard acquisition, deleveraging ⚠️
• Interest Income / Revenue: Well under 5% ✅
• Haram Revenue: Negligible ✅
• Business Activity: Permissible medical technology ✅

Verdict from Major Screening Agencies

Becton Dickinson stock is generally screened as compliant (halal) with purification by:

• Zoya App — Compliant with purification ✅
• MSCI Islamic criteria — Generally included ✅
• Most major Sharia advisory boards — Compliant with purification of small interest-income component, subject to verifying leverage ✅

Bottom Line

Becton Dickinson (BDX) is generally halal with purification for Muslim investors. The core business — medical devices, diagnostics, and life-sciences instruments — is unambiguously permissible at the activity level, and the financial screen passes subject to verifying the post-Bard leverage against the 33% threshold.

For Muslim investors seeking large-cap medical-technology exposure, BDX sits alongside other halal-screened healthcare-equipment names like Boston Scientific (BSX), Medtronic (MDT), Stryker (SYK), and Danaher (DHR).